Individual investors acquire 30% stake in Wooridul Pharm

Published: 2010-07-15 06:56:00

Updated: 2010-07-15 06:56:00

Wooridul Pharm said in its regulatory filing on July 6 that a group of individual investors bought 30% stake in Wooridul Pharm to jump into hospital related business sectors.

The individual investor group, led by Park Joon-hyung (43), said it will complete the stake acquisition work in Wooridu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK